Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | 93,600 | reported | 03 Jan 2023 | tx 8+305,143−17,102 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jan 2023 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 93,600 | 0.00 USD | deriv |
| 06 Jan 2022 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 70,967 | 0.00 USD | deriv |
| 30 Dec 2021 | EXERCISE | Werewolf Therapeutics, Inc. | 14,102 | 1.56 USD | |
| 30 Dec 2021 | EXERCISE | Werewolf Therapeutics, Inc. | 14,102 | 0.00 USD | deriv |
| 15 Dec 2021 | SALE | Werewolf Therapeutics, Inc. | 135 | 13.97 USD | |
| 15 Dec 2021 | SALE | Werewolf Therapeutics, Inc. | 2,865 | 13.39 USD | |
| 08 Dec 2020 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 99,163 | 0.00 USD | deriv |
| 30 Apr 2021 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 27,311 | 0.00 USD | deriv |